FGF21 and steatosis: Although overall we did witness a reduction in steatosis following HCV eradication, its lack of correlation with FGF-21 may be due to confounding factors related to a divergence in the pathogenetic mechanisms, which, despite sharing parts of the molecular pathway, present different clinical and prognostic implications.